VENUS REMEDIES LTD.

The current price of VENUSREM is 330.75 INR — it has decreased by 0.91% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange VENUS REMEDIES LTD. stocks are traded under the ticker VENUSREM.

VENUS REMEDIES LTD. is going to release the next earnings report on May 30, 2024. Keep track of upcoming events with our Earnings Calendar.

VENUSREM stock is 1.41% volatile and has beta coefficient of 0.47. Check out the list of the most volatile stocks — is VENUS REMEDIES LTD. there?

Yes, you can track VENUS REMEDIES LTD. financials in yearly and quarterly reports right on TradingView.

VENUSREM stock has risen by 3.04% compared to the previous week, the month change is a 0.55% rise, over the last year VENUS REMEDIES LTD. has showed a 70.67% increase.

Today VENUS REMEDIES LTD. has the market capitalization of ‪4.46 B‬, it has decreased by 2.36% over the last week.

No, VENUSREM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, VENUSREM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VENUS REMEDIES LTD. stock right from TradingView charts — choose your broker and connect to your account.

VENUSREM reached its all-time high on Aug 9, 2021 with the price of 638.50 INR, and its all-time low was 3.85 INR and was reached on Mar 23, 2004.
See other stocks reaching their highest and lowest prices.

As of Apr 23, 2024, the company has 998.00 employees. See our rating of the largest employees — is VENUS REMEDIES LTD. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VENUS REMEDIES LTD. technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VENUS REMEDIES LTD. stock shows the buy signal. See more of VENUS REMEDIES LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VENUS REMEDIES LTD. EBITDA is ‪648.40 M‬ INR, and current EBITDA margin is 10.77%. See more stats in VENUS REMEDIES LTD. financial statements.